This book focusses on the shift away from animal testing towards alternative approaches in toxicology, drug development, and biomedical research. It draws attention to the difficulties and possibilities brought about by this change, highlighting moral issues, legal frameworks, and real-world applications. Biomedical research is changing quickly due to the increasing ethical pressure to minimize animal testing. Traditional research methods are coming under more and more scrutiny as a result of public concern over animal welfare. Concurrently, novel approaches like organ-on-a-chip technology, 3D bioprinting, and in silico models present encouraging substitutes. In order to provide academicians and policymakers with up-to-date information on developing trends in this sector, this book attempts to compile existing knowledge on the aforementioned innovations beyond animal testing. The different chapters emphasize the potential solutions and opportunities offered by alternative methods. They provide practical insights and strategies for researchers and policymakers looking to transition away from animal models. The book also addresses the critical topic of economic efficiency by showing how affordable non-animal models may be, which could lessen the financial burden of research. The book serves as a significant educational resource, specifically designed for students, educators, researchers and health care professionals. This will aid early career researchers having limited resources in generating preliminary data and proof of concept for further research. It also addresses the market's need for actionable information by providing practical advice on how healthcare professionals can use these cutting-edge tactics in promoting emergency use of drug and delivery system without actually testing them in vivo.